Yes — most private-sector employers can generally drug test, and in some industries (transportation, aviation, federal contractors with sensitive positions) federal rules actually require it. But drug testing in employment is a state-law-driven area: state law adds substantial restrictions in many cases, including procedural rules, testing methods, and — increasingly — protections for marijuana use outside of work in legalization states. The trend over the last decade has generally been toward restricting employer use of drug tests, particularly for marijuana, where state legalization has created complex compliance questions. The specifics depend on your situation, and these rules and figures continue to change.
Federal baseline
- Most private employers: Federal law generally permits pre-employment, random, post-accident, and reasonable-suspicion drug testing, with no specific federal procedural requirements layered on top.
- DOT-regulated employees: The U.S. Department of Transportation generally requires testing for safety-sensitive positions (commercial drivers, pilots, transit workers, pipeline operators, etc.). Specific Federal Motor Carrier Safety Administration and DOT procedures typically apply.
- Federal contractors: The federal Drug-Free Workplace Act generally requires drug-free workplace policies for contractors with contracts over a threshold. It does not require testing per se, but is commonly read to support testing programs.
- ADA implications: The EEOC treats a test for current illegal drug use as generally not an ADA-prohibited medical examination. But testing for legal prescription drugs or post-rehabilitation may implicate ADA protections for individuals in recovery — how this plays out depends on your situation.
How does this vary by state?
State drug testing laws vary across several dimensions, and your state may differ from the patterns below:
- Notice and policy requirements: Many states generally require employers to have a written drug testing policy provided to employees in advance.
- Confirmation testing: Most states generally require a confirmation test (GC/MS or similar) before any positive result triggers adverse action.
- MRO review: Many states generally require a Medical Review Officer to review positive results, particularly to evaluate prescription medications.
- Random testing limits: Some states generally restrict random testing to safety-sensitive positions.
- Marijuana-specific protections: Many legalization states now generally prohibit adverse action based on off-duty marijuana use:
- California: AB 2188 (operative 2024) generally prohibits adverse action based on off-duty cannabis use detected by tests measuring non-psychoactive metabolites.
- New York: The Marijuana Regulation and Taxation Act is generally read to protect off-duty cannabis use.
- Washington: SB 5123 (enacted 2023, operative 2024) generally prohibits pre-employment testing for non-psychoactive cannabis metabolites for most positions.
- Nevada, New Jersey, Illinois, Connecticut, Montana, Minnesota, and others: Varying levels of off-duty marijuana protection.
- Safety-sensitive carve-outs: Most marijuana protection statutes generally carve out safety-sensitive positions, federal contractors, and federally regulated industries.
How do you evaluate your situation?
1. Understanding your jurisdiction's rules
A common first step is to pull your state's drug testing statute (if any) and look at:
- Whether pre-employment, random, post-accident, and reasonable-suspicion testing are generally permitted
- What notice and policy requirements apply
- What testing methods are required (urinalysis, oral fluid, hair, etc.)
- What confirmation procedures apply
- What marijuana-specific protections apply
2. Identifying whether your position is "safety-sensitive"
This is the critical carve-out in most marijuana-protection statutes. Definitions vary by state, but they typically include:
- Positions requiring federal regulation (DOT, FAA, etc.)
- Positions involving operation of heavy machinery or vehicles
- Positions with direct responsibility for the safety of others
- Positions handling controlled substances or hazardous materials
Where a position is not safety-sensitive, marijuana protections are generally more likely to apply — though the specific definition that controls depends on your state.
3. Documenting the testing process
When asked to take a drug test, many people:
- Get a copy of the employer's drug testing policy
- Note the testing facility, date, time, and method
- Keep a copy of the consent form and any disclosures
- Disclose any prescription medications (in writing, with documentation)
- Retain any test results and MRO communications
4. Responding to positive results
After notice of a positive test, a common set of steps people take is to:
- Request the specific test result and the laboratory documentation
- Request the MRO interview (a step employers sometimes skip)
- Disclose any prescription medications that may explain the result
- For marijuana in protection states, raise the statutory protection promptly
Scripts to use
To request the drug testing policy in advance:
"I'd like to request a copy of the company's written drug testing policy before consenting to any testing. Specifically, I'd like to understand the testing methods used, the substances tested, the confirmation procedures, and the consequences of various results."
To disclose prescription medications:
"I want to disclose, before any testing, that I am currently taking [medication] under prescription from [physician] for [condition]. I have documentation. I am providing this proactively to ensure proper MRO review of any results."
Responding to a positive marijuana result in a protection state:
"Under [state statute, e.g., California AB 2188 / NY Marijuana Regulation and Taxation Act], adverse employment action based on off-duty cannabis use is prohibited. My position is not safety-sensitive under the statutory definition. I am asking that the test result not be used as a basis for adverse action."
Disputing a positive result:
"I have reviewed the test result and want to dispute the finding. I am requesting: (a) the specific laboratory documentation, (b) the MRO review and any interview opportunity, (c) the chain of custody documentation, and (d) the opportunity to provide a confirmation sample for independent retesting at my expense."
What should you keep on file?
Many people find it helps to hold on to:
- The employer's drug testing policy
- Any disclosure or authorization signed
- The testing facility, date, time, method, and chain of custody
- The test results (initial and confirmation, if applicable)
- The MRO review and any communications
- Prescription medication documentation, if relevant
- The job description and whether it qualifies as "safety-sensitive"
- Any state-specific protections that apply
When should you escalate?
If you believe an employer violated drug testing rules, common avenues people use include:
- Filing a complaint with your state department of labor for state-statute violations.
- Filing with the EEOC where the testing may implicate the ADA (post-rehabilitation discrimination) or other anti-discrimination protections.
- Consulting an employment attorney for marijuana protection violations — many states generally provide a private right of action with damages and attorney's fees.
- For DOT-regulated testing, raising complaints with the relevant federal agency.
The marijuana protection statutes are relatively new and the case law is still developing, so outcomes can vary and these rules continue to change. Many people find that documenting the precise position duties (and whether they meet the "safety-sensitive" definition) is one of the most useful things they can do if they want to push back on adverse action.
Official sources
- U.S. Equal Employment Opportunity Commission — Enforcement Guidance on Disability-Related Inquiries and Medical Examinations of Employees under the ADA (covers when drug testing is and is not a medical examination)
- California Legislature — AB 2188 (2022): Discrimination in employment: use of cannabis (off-duty cannabis-use protections, operative 2024)